107 related articles for article (PubMed ID: 26820810)
1. Co-expression of FOXL1 and PP2A inhibits proliferation inducing apoptosis in pancreatic cancer cells via promoting TRAIL and reducing phosphorylated MYC.
Li Y; Yu D; Sheng W; Song H; Li Y; Dong M
Oncol Rep; 2016 Apr; 35(4):2198-206. PubMed ID: 26820810
[TBL] [Abstract][Full Text] [Related]
2. FOXL1, a novel candidate tumor suppressor, inhibits tumor aggressiveness and predicts outcome in human pancreatic cancer.
Zhang G; He P; Gaedcke J; Ghadimi BM; Ried T; Yfantis HG; Lee DH; Hanna N; Alexander HR; Hussain SP
Cancer Res; 2013 Sep; 73(17):5416-25. PubMed ID: 23801748
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Forkhead Box L1 (FOXL1) Inhibits the Proliferation and Invasion of Breast Cancer Cells.
Zhong J; Wang H; Yu J; Zhang J; Wang H
Oncol Res; 2017 Jul; 25(6):959-965. PubMed ID: 27938507
[TBL] [Abstract][Full Text] [Related]
4. Forkhead box L1 is frequently downregulated in gallbladder cancer and inhibits cell growth through apoptosis induction by mitochondrial dysfunction.
Qin Y; Gong W; Zhang M; Wang J; Tang Z; Quan Z
PLoS One; 2014; 9(7):e102084. PubMed ID: 25010679
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of forkhead box L1 gene on osteosarcoma growth through the induction of cell cycle arrest and apoptosis.
Chen X; Deng M; Ma L; Zhou J; Xiao Y; Zhou X; Zhang C; Wu M
Oncol Rep; 2015 Jul; 34(1):265-71. PubMed ID: 26062977
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Src-PP2A interaction in tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis.
Xu J; Xu Z; Zhou JY; Zhuang Z; Wang E; Boerner J; Wu GS
J Biol Chem; 2013 Nov; 288(46):33263-71. PubMed ID: 24100030
[TBL] [Abstract][Full Text] [Related]
7. Activation of PP2A and Inhibition of mTOR Synergistically Reduce MYC Signaling and Decrease Tumor Growth in Pancreatic Ductal Adenocarcinoma.
Allen-Petersen BL; Risom T; Feng Z; Wang Z; Jenny ZP; Thoma MC; Pelz KR; Morton JP; Sansom OJ; Lopez CD; Sheppard B; Christensen DJ; Ohlmeyer M; Narla G; Sears RC
Cancer Res; 2019 Jan; 79(1):209-219. PubMed ID: 30389701
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of PP2A activity confers a TRAIL-sensitive phenotype during malignant transformation.
Yang H; Chen X; Wang X; Li Y; Chen S; Qian X; Wang R; Chen L; Han W; Ruan A; Du Q; Olumi AF; Zhang X
Mol Cancer Res; 2014 Feb; 12(2):217-27. PubMed ID: 24296757
[TBL] [Abstract][Full Text] [Related]
9. Protein phosphatase 2A activation as a therapeutic strategy for managing MYC-driven cancers.
Farrington CC; Yuan E; Mazhar S; Izadmehr S; Hurst L; Allen-Petersen BL; Janghorban M; Chung E; Wolczanski G; Galsky M; Sears R; Sangodkar J; Narla G
J Biol Chem; 2020 Jan; 295(3):757-770. PubMed ID: 31822503
[TBL] [Abstract][Full Text] [Related]
10. Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer.
Janghorban M; Farrell AS; Allen-Petersen BL; Pelz C; Daniel CJ; Oddo J; Langer EM; Christensen DJ; Sears RC
Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9157-62. PubMed ID: 24927563
[TBL] [Abstract][Full Text] [Related]
11. Targeting inhibitors of the tumor suppressor PP2A for the treatment of pancreatic cancer.
Farrell AS; Allen-Petersen B; Daniel CJ; Wang X; Wang Z; Rodriguez S; Impey S; Oddo J; Vitek MP; Lopez C; Christensen DJ; Sheppard B; Sears RC
Mol Cancer Res; 2014 Jun; 12(6):924-39. PubMed ID: 24667985
[TBL] [Abstract][Full Text] [Related]
12. Protein Phosphatase 2a Inhibits Gastric Cancer Cell Glycolysis by Reducing MYC Signaling.
Cai Z; Zhang W; Zhou R; Wang Y; Feng Y
Cell Biochem Biophys; 2023 Mar; 81(1):59-68. PubMed ID: 36324030
[TBL] [Abstract][Full Text] [Related]
13. Curcumin induces apoptosis in pancreatic cancer cells through the induction of forkhead box O1 and inhibition of the PI3K/Akt pathway.
Zhao Z; Li C; Xi H; Gao Y; Xu D
Mol Med Rep; 2015 Oct; 12(4):5415-22. PubMed ID: 26166196
[TBL] [Abstract][Full Text] [Related]
14. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase inhibitors sensitize glioblastoma cells to TRAIL-induced apoptosis by c-myc-mediated downregulation of cFLIP.
Bangert A; Cristofanon S; Eckhardt I; Abhari BA; Kolodziej S; Häcker S; Vellanki SH; Lausen J; Debatin KM; Fulda S
Oncogene; 2012 Nov; 31(44):4677-88. PubMed ID: 22266862
[TBL] [Abstract][Full Text] [Related]
16. Nuclear death receptor TRAIL-R2 inhibits maturation of let-7 and promotes proliferation of pancreatic and other tumor cells.
Haselmann V; Kurz A; Bertsch U; Hübner S; Olempska-Müller M; Fritsch J; Häsler R; Pickl A; Fritsche H; Annewanter F; Engler C; Fleig B; Bernt A; Röder C; Schmidt H; Gelhaus C; Hauser C; Egberts JH; Heneweer C; Rohde AM; Böger C; Knippschild U; Röcken C; Adam D; Walczak H; Schütze S; Janssen O; Wulczyn FG; Wajant H; Kalthoff H; Trauzold A
Gastroenterology; 2014 Jan; 146(1):278-90. PubMed ID: 24120475
[TBL] [Abstract][Full Text] [Related]
17. RABL6A inhibits tumor-suppressive PP2A/AKT signaling to drive pancreatic neuroendocrine tumor growth.
Umesalma S; Kaemmer CA; Kohlmeyer JL; Letney B; Schab AM; Reilly JA; Sheehy RM; Hagen J; Tiwari N; Zhan F; Leidinger MR; O'Dorisio TM; Dillon J; Merrill RA; Meyerholz DK; Perl AL; Brown BJ; Braun TA; Scott AT; Ginader T; Taghiyev AF; Zamba GK; Howe JR; Strack S; Bellizzi AM; Narla G; Darbro BW; Quelle FW; Quelle DE
J Clin Invest; 2019 Mar; 129(4):1641-1653. PubMed ID: 30721156
[TBL] [Abstract][Full Text] [Related]
18. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
Song J; Cao L; Li Y
Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
[TBL] [Abstract][Full Text] [Related]
19. Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
Li W; Chen Z; Gong FR; Zong Y; Chen K; Li DM; Yin H; Duan WM; Miao Y; Tao M; Han X; Xu ZK
Eur J Cancer; 2011 Nov; 47(17):2654-64. PubMed ID: 21958460
[TBL] [Abstract][Full Text] [Related]
20. MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways.
Hoshi H; Sawada T; Uchida M; Iijima H; Kimura K; Hirakawa K; Wanibuchi H
Int J Oncol; 2013 Mar; 42(3):887-93. PubMed ID: 23292004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
